Find a Tender
complete
Official procurement procedure
NP35923 Cardiovascular & Respiratory Medicines
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published15
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"): "NP35923 Cardiovascular & Respiratory Medicines". Published status: complete. Published value: Value not published. 15 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
9.9Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 974 active published awards; 798 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published25 Jul 2023, 10:16 BST | Last source update25 Jul 2023, 10:16 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-03967f | ||
What is being bought
This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods were split into eighteen (18) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
What changed
From the official release history
- tender value changed
25 Jul 2023, 10:16 BST - Status changed to complete
25 Jul 2023, 10:16 BST - Official notice release published
25 Jul 2023, 10:16 BST - Submission deadline changed to published date
25 Jul 2023, 10:16 BST - Published value updated to £56,782,632
11 Jan 2023, 11:36 GMT - Status changed to active
11 Jan 2023, 11:36 GMT - Official notice release published
11 Jan 2023, 11:36 GMT - Submission deadline changed to 10 Feb 2023, 17:00 GMT
11 Jan 2023, 11:36 GMT - Buyer information updated
11 Jan 2023, 11:36 GMT
Lots and requirements (15)
Published by the contracting authority
- Lot 1 · #10Nifedipine Modified Release Capsules and TabletscancelledPublished valueNot publishedSupply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #11Theophylline Modified Release Capsules and TabletscancelledPublished valueNot publishedSupply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #12Branded and Branded Generic InhalerscancelledPublished valueNot publishedSupply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #13Iloprost MedicinescancelledPublished valueNot publishedSupply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #14Dalteparin InjectioncancelledPublished valueNot publishedSupply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #15Tinzaparin Sodium InjectioncancelledPublished valueNot publishedSupply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #16Icatibant Solution for InjectioncancelledPublished valueNot publishedSupply of Icatibant Solution for Injection to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 8 · #17Tresprostinil InjectioncancelledPublished valueNot publishedSupply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 9 · #18All other Cardiovascular & Respiratory MedicinescancelledPublished valueNot publishedSupply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line was treated as an individual Lot. The Authority has awarded each product line to a single Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 10 · #2Epoprostenol powder and solvent (pH12) for solution for infusion vialscancelledPublished valueNot publishedSupply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority has awarded a multi-supplier unranked framework agreement for the Lot to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 11 · #3Epinepherine (Adrenaline) Pre-filled syringescancelledPublished valueNot publishedSupply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 12 · #5Enoxaparin Sodium InjectioncancelledPublished valueNot publishedSupply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 13 · #7Isosorbide Mononitrate Modified Release Capsules and TabletscancelledPublished valueNot publishedSupply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 14 · #8Diltiazem Hydrochloride Modified Release Capsules and TabletscancelledPublished valueNot publishedSupply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 15 · #9Verapamil Hydrochloride Modified Release Capsules and TabletscancelledPublished valueNot publishedSupply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
25 Jul 2023, 10:16 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 3 Apr 2023, 00:00 BST · £4,360,152 - Contract active
Signed 3 Apr 2023, 00:00 BST · £687,053 - Contract active
Signed 3 Apr 2023, 00:00 BST · £13,611,251 - Contract active
Signed 3 Apr 2023, 00:00 BST · £1,354,476 - Contract active
Signed 3 Apr 2023, 00:00 BST · £95,013 - Contract active
Signed 3 Apr 2023, 00:00 BST · £89,320 - Contract active
Signed 3 Apr 2023, 00:00 BST · £18,729,687 - Contract active
Signed 3 Apr 2023, 00:00 BST · £714,020 - Contract active
Signed 3 Apr 2023, 00:00 BST · £10,095,071 - Contract active
Signed 3 Apr 2023, 00:00 BST · £42,957 - Contract active
Signed 3 Apr 2023, 00:00 BST · £58,174 - Contract active
Signed 3 Apr 2023, 00:00 BST · £24,024 - Contract active
Signed 3 Apr 2023, 00:00 BST · £8,693 - Contract active
Signed 3 Apr 2023, 00:00 BST · £25,699 - Contract active
Signed 3 Apr 2023, 00:00 BST · £3,451,061
Commercial outcome and competition
Awards GlaxoSmithKline Not published · Not published · active Colonis Pharma Ltd, Zentiva Pharma UK Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active LEO Pharma Not published · Not published · active Glenmark Pharmaceuticals Europe Ltd, Martindale Pharma, Sandoz Ltd Not published · Not published · active AOP Orphan Ltd, Dr Reddy's Laboratories (UK) Ltd Not published · Not published · active Accord-UK Ltd, Aguettant Ltd, Aspire Pharma Ltd, Aventis Pharma Ltd Trading As Sanofi, Baxter Healthcare Ltd, Beaumont Pharma Ltd, Bowmed Ibisqus Limited, CST Pharma Ltd, Chiesi Limited, Consilient Health Ltd, Correvio GmbH, Crescent Pharma Limited, Day Lewis Medical Ltd, Dr Reddy's Laboratories (UK) Ltd, Ennogen Healthcare Ltd Not published · Not published · active Martindale Pharma Not published · Not published · active Aventis Pharma Ltd Trading As Sanofi, CST Pharma Ltd, Day Lewis Medical Ltd, ROVI Biotech Limited, Techdow Pharma England Ltd, Tetris Pharma Ltd Not published · Not published · active Accord-UK Ltd, Esteve Pharmaceuticals Ltd, Martindale Pharma, Mercury Pharma Group, Thornton & Ross Not published · Not published · active Aventis Pharma Ltd Trading As Sanofi, Martindale Pharma, Thornton & Ross, Zentiva Pharma UK Ltd Not published · Not published · active Selective Supplies Ltd Not published · Not published · active Focus Pharmaceuticals Ltd, Mercury Pharma Group, Thornton & Ross Not published · Not published · active Ennogen Healthcare Ltd Not published · Not published · active Accord-UK Ltd, Chiesi Limited, Day Lewis Medical Ltd, GlaxoSmithKline, Glenmark Pharmaceuticals Europe Ltd, Lupin (Europe) Limited, Sandoz Ltd, Selective Supplies Ltd, Teva UK Limited, Thornton & Ross, Wockhardt UK Limited, Zentiva Pharma UK Ltd Not published · Not published · active |
Contracts Epoprostenol powder and solvent (pH12) for solution for infusion vials £4,360,152 · signed 3 Apr 2023, 00:00 BST · active Iloprost Medicines £687,053 · signed 3 Apr 2023, 00:00 BST · active Dalteparin Injection £13,611,251 · signed 3 Apr 2023, 00:00 BST · active Tinzaparin Sodium Injection £1,354,476 · signed 3 Apr 2023, 00:00 BST · active Icatibant Solution for Injection £95,013 · signed 3 Apr 2023, 00:00 BST · active Tresprostinil Injection £89,320 · signed 3 Apr 2023, 00:00 BST · active All other Cardiovascular & Respiratory Medicines £18,729,687 · signed 3 Apr 2023, 00:00 BST · active Epinepherine (Adrenaline) Pre-filled syringes £714,020 · signed 3 Apr 2023, 00:00 BST · active Enoxaparin Sodium Injection £10,095,071 · signed 3 Apr 2023, 00:00 BST · active Isosorbide Mononitrate Modified Release Capsules and Tablets £42,957 · signed 3 Apr 2023, 00:00 BST · active Diltiazem Hydrochloride Modified Release Capsules and Tablets £58,174 · signed 3 Apr 2023, 00:00 BST · active Verapamil Hydrochloride Modified Release Capsules and Tablets £24,024 · signed 3 Apr 2023, 00:00 BST · active Nifedipine Modified Release Capsules and Tablets £8,693 · signed 3 Apr 2023, 00:00 BST · active Theophylline Modified Release Capsules and Tablets £25,699 · signed 3 Apr 2023, 00:00 BST · active Branded and Branded Generic Inhalers £3,451,061 · signed 3 Apr 2023, 00:00 BST · active |
Bid statistics bids: 3 (lot 10) electronicBids: 3 (lot 10) foreignBidsFromEU: 0 (lot 10) foreignBidsFromNonEU: 3 (lot 10) smeBids: 3 (lot 10) bids: 1 (lot 11) electronicBids: 1 (lot 11) foreignBidsFromEU: 0 (lot 11) foreignBidsFromNonEU: 1 (lot 11) smeBids: 1 (lot 11) bids: 12 (lot 12) electronicBids: 12 (lot 12) foreignBidsFromEU: 0 (lot 12) foreignBidsFromNonEU: 12 (lot 12) smeBids: 10 (lot 12) bids: 2 (lot 13) electronicBids: 2 (lot 13) foreignBidsFromEU: 0 (lot 13) foreignBidsFromNonEU: 2 (lot 13) smeBids: 1 (lot 13) bids: 1 (lot 14) electronicBids: 1 (lot 14) foreignBidsFromEU: 0 (lot 14) foreignBidsFromNonEU: 1 (lot 14) smeBids: 1 (lot 14) bids: 1 (lot 15) electronicBids: 1 (lot 15) foreignBidsFromEU: 0 (lot 15) foreignBidsFromNonEU: 1 (lot 15) smeBids: 1 (lot 15) bids: 6 (lot 16) electronicBids: 6 (lot 16) foreignBidsFromEU: 0 (lot 16) foreignBidsFromNonEU: 6 (lot 16) smeBids: 5 (lot 16) bids: 2 (lot 17) electronicBids: 2 (lot 17) foreignBidsFromEU: 0 (lot 17) foreignBidsFromNonEU: 2 (lot 17) smeBids: 2 (lot 17) bids: 43 (lot 18) electronicBids: 43 (lot 18) foreignBidsFromEU: 1 (lot 18) foreignBidsFromNonEU: 42 (lot 18) smeBids: 32 (lot 18) bids: 1 (lot 2) electronicBids: 1 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 1 (lot 2) smeBids: 0 (lot 2) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contracting authority GB-FTS-322Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published